PROFIL PENGOBATAN OBAT ISPA NON PNEUMONIA PADA ANAK DI PUSKESMAS MANTANG LOMBOK TENGAH
DOI:
https://doi.org/10.33651/jpkik.v8i2.356Keywords:
acute respiratory infection, prescription profile, non pneumonia, health centerAbstract
Acute Respiratory Infection (ARI) is an acute infection that attacks the organs of the upper respiratory tract and lower respiratory tract. Acute respiratory infection is a disease that mostly affects children and adults in developing and developed countries. Non-pneumonic acute respiratory tract infections include a group of patients with under-fives with a cough that does not show symptoms of an increase in respiratory rate and does not show any pull from the lower chest wall. This study aims to see the description of ARI non-pneumonia treatment at the Mantang Health Center, Central Lombok. Sampling in this study used all patients who met the inclusion criteria, and data obtained were 21 patients with a diagnosis of ARI Non Pneumonia in children from 665 patient populations. The results obtained in this study were obtained the most patients, namely patients aged 4-6 years with a percentage of 42.85%, ages 1-3 years 7 with a percentage of 33.33%, age < 6 months of 14.28% and 6-12 months with a percentage of 14.28%. The classes of drugs prescribed for the May 2021 period are antibiotics, antihistamines, analgesics, mucolytics, anti-inflammatory, and multivitamins . The conclusion obtained in this study is that pediatric patients with ARI Non-Pneumonia at the Mantang Health Center who received the most treatment at the age of 4-6 years had the highest percentage and received the most therapy with a diagnosis of ARI Non-Pneumonia, which was given antihistamins
References
Adamou L, Halima BM, Bassira I, Ali S, Stefano T. 2015. Viral and bacterial aetiology of severe acute respiratory illness among children <5 years of age without influenza in Niger. BMC Infect Dis. 2015 : 15:515. DOI 10.1186/s12879-015-1251-y.
Direktorat Jendral Pengendalian Penyakit. 2011. Pedoman Penaggulangan Penyakit Infeksi Saluran Pernapasan Akut. Jakarta: Kementrian Kesehatan Republik Indonesia.
Departemen Kesehatan Republik Indonesia. 2012. Profil Kesehatan Indonesia 2011. Jakarta: Departemen Kesehatan Republik Indonesia.
DiPiro J.T., Wells B.G., Schwinghammer T.L. and DiPiro C. V. 2015. Pharmacotherapy Handbook, Ninth Edit. Inggris. McGraw-Hill Education National Institute For Health and Care Excellence. 2018. Otitis Media (Acute): Antimicrobial Prescribing Companies.
Dorland, W. A. Newmann. 2014. Kamus Saku Kedokteran Dorlan, Ed ke-28. Jakarta : EGC.
Dawson-Caswell M, Muncie HL Jr. 2011. Respiratory syncytial virus infection in children. Am Fam Physician. 2011; 83(2) : 141–6. PMID : 21243988.
Danusantoso H. 2013. Buku Saku Ilmu Penyakit Paru, Ed Ke 2. Jakarta : Penerbit Buku Kedokteran EGC.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. Mar(23): 1-298.
Hartono, R dan Rahmawati D.H. 2016. Gangguan Pernafasan Pada Anak : ISPA. Yogyakarta : Nuha Medika.
Hazen, C.K. 2014. Respiratory Fungal Infections Molecular Diagnostic Tests. Clinical Laboratory Med 34 (2014) 351–364
Irma, O., Sri, H. and Eva S. 2014. Faktor-Faktor yang Berhubungan dengan Kejadian Infeksi Saluran Pernafasan Akut (ISPA) pada Balita di Puskesmas Garuda Kota Bandung. Jurnal Ilmu Keperawatan.
I Made Agus Sunadi Putra IGAAKW. Profiles the Use of Antibiotics for Acute Infectious Nonpneumonia. 2015;3(1):1–6.
Kemenkes RI, 2011, Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik, Direktorat Jenderal BinaKefarmasianDanAlatKesehatan,Jakarta.
Kementerian Kesehatan Republik Indonesia. Peraturan Menkes RI Nomor 75 Tahun 2014, Pusat Kesehatan Masyarakat. Jakarta: Kementrian Kesehatan Republik Indonesia; 2014.
Kementrian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia 2015. Jakarta : Kementrian Kesehatan Republik Indonesia. 2016.
Maharni D., Yani F. F and Lestari Y. 2017. Profil Balita Penderita Infeksi Saluran Pernafasan Akut (ISPA) Pasien Pediatrik Rawat Inap di RSUD Karanganyar Bulan November 2013-Maret 2014. Indonesian Journal an Medical Science (1).
Maneghetii Anne, MD. 2018. Upper Respiratory Infections : Practice Essentials, Background, Pathofisiology.
National Institute For Health and Care Excellence. 2018. Otitis Media (Acute): Antimicrobial Prescribing
Notoadmodjo,S (2013). Methodologi penelitian keperawatan. Jakarta: Rineka cipta.
Pretorius MA, Madhi SA, Cohen C, Naidoo D, Groome M, Moyes J, et al. 2012. Respiratory viral coinfections identified by a 10-plex real-time reverse transcription polymerase chain reaction assay in patients hospitalised with severe acute respiratory illness–South Africa, 2009–2010. J Infect Dis. 2012;206 Suppl 1:S159–65.
Sri, H,. 2014. Gambaran Faktor Penyebab Infeksi Saluran Pernafasan Akut (ISPA) pada Balita di Puskesmas Pasirkaliki Kota Bandung. Jurnal Ilmu Keperawatan.
Scadding, G.K., Kariyawasam, H.H., Scadding, G et al. 2017. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clinical and Experimental Allergy 47, 856–889.
Syafarilla, I. 2011. Hubungan Status Sosial Ekonomi Keluarga dengan Kejadian Infeksi Saluran Pernapasan Akut Pada Balita.
World Health Organization. 2014. Pneumonia.
World Health Organization. 2012. Acute Respiratory Infections. https://www.who.int/maternal_child_adolescent/documents/respirato ry/en/.
Published
How to Cite
Issue
Section
JPKIK : Jurnal Peneliian dan Kajian Ilmiah kesehatan is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
You are free to :
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms :
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
